203 related articles for article (PubMed ID: 37443105)
1. Macrophage DCLK1 promotes obesity-induced cardiomyopathy via activating RIP2/TAK1 signaling pathway.
Yang B; Zhao Y; Luo W; Zhu W; Jin L; Wang M; Ye L; Wang Y; Liang G
Cell Death Dis; 2023 Jul; 14(7):419. PubMed ID: 37443105
[TBL] [Abstract][Full Text] [Related]
2. Macrophage DCLK1 promotes atherosclerosis via binding to IKKβ and inducing inflammatory responses.
Huang Z; Shen S; Han X; Li W; Luo W; Lin L; Xu M; Wang Y; Huang W; Wu G; Liang G
EMBO Mol Med; 2023 May; 15(5):e17198. PubMed ID: 36896602
[TBL] [Abstract][Full Text] [Related]
3. Blockage of DCLK1 in cardiomyocytes suppresses myocardial inflammation and alleviates diabetic cardiomyopathy in streptozotocin-induced diabetic mice.
Ji L; Yang X; Jin Y; Li L; Yang B; Zhu W; Xu M; Wang Y; Wu G; Luo W; Lee K; Liang G
Biochim Biophys Acta Mol Basis Dis; 2024 Jan; 1870(1):166900. PubMed ID: 37778481
[TBL] [Abstract][Full Text] [Related]
4. CARD9 knockout ameliorates myocardial dysfunction associated with high fat diet-induced obesity.
Cao L; Qin X; Peterson MR; Haller SE; Wilson KA; Hu N; Lin X; Nair S; Ren J; He G
J Mol Cell Cardiol; 2016 Mar; 92():185-95. PubMed ID: 26900039
[TBL] [Abstract][Full Text] [Related]
5. FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress.
Geng Z; Fan WY; Zhou B; Ye C; Tong Y; Zhou YB; Xiong XQ
J Transl Med; 2019 Apr; 17(1):107. PubMed ID: 30940158
[TBL] [Abstract][Full Text] [Related]
6. CTRP9 knockout exaggerates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy through inhibiting the LKB1/AMPK pathway.
Zuo A; Zhao X; Li T; Li J; Lei S; Chen J; Xu D; Song C; Liu T; Li C; Guo Y
J Cell Mol Med; 2020 Feb; 24(4):2635-2647. PubMed ID: 31930700
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of TAK1/TAB2 complex formation by costunolide attenuates obesity cardiomyopathy via the NF-κB signaling pathway.
Ye B; Chen X; Chen Y; Lin W; Xu D; Fang Z; Chattipakorn N; Huang W; Wang X; Wu G; Liang G
Phytomedicine; 2023 Jan; 108():154523. PubMed ID: 36332385
[TBL] [Abstract][Full Text] [Related]
8. Zinc deficiency exacerbates while zinc supplement attenuates cardiac hypertrophy in high-fat diet-induced obese mice through modulating p38 MAPK-dependent signaling.
Wang S; Luo M; Zhang Z; Gu J; Chen J; Payne KM; Tan Y; Wang Y; Yin X; Zhang X; Liu GC; Wintergerst K; Liu Q; Zheng Y; Cai L
Toxicol Lett; 2016 Sep; 258():134-146. PubMed ID: 27346292
[TBL] [Abstract][Full Text] [Related]
9. Doublecortin-like kinase 1 activates NF-κB to induce inflammatory responses by binding directly to IKKβ.
Luo W; Jin Y; Jiang Y; Yang L; Xu H; Wu D; Zhang Y; Yin L; Khan ZA; Liang G; Wang Y
Cell Death Differ; 2023 May; 30(5):1184-1197. PubMed ID: 36914767
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway.
Kuwabara Y; Horie T; Baba O; Watanabe S; Nishiga M; Usami S; Izuhara M; Nakao T; Nishino T; Otsu K; Kita T; Kimura T; Ono K
Circ Res; 2015 Jan; 116(2):279-88. PubMed ID: 25362209
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 deficiency facilitates myocardial dysfunction during high fat diet-induced obesity by promoting lipotoxicity and inflammation.
Chen F; Chen D; Zhao X; Yang S; Li Z; Sanchis D; Jin L; Qiang X; Wang K; Xu Y; Zhang Y; Ye J
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3128-3141. PubMed ID: 28844956
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of MyD88 by LM8 Attenuates Obesity-Induced Cardiac Injury.
Liu H; Jia W; Tang Y; Zhang W; Qi J; Yan J; Ding W; Cao H; Liang G; Zhu Z; Zheng H; Zhang Y
J Cardiovasc Pharmacol; 2020 Jul; 76(1):63-70. PubMed ID: 32398475
[TBL] [Abstract][Full Text] [Related]
13. RIP2 inhibition alleviates lipopolysaccharide-induced septic cardiomyopathy via regulating TAK1 signaling.
Lin Z; Liao HH; Zhou ZY; Zhang N; Li WJ; Tang QZ
Eur J Pharmacol; 2023 May; 947():175679. PubMed ID: 36967078
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of myeloid differentiation factor-2 attenuates obesity-induced cardiomyopathy and fibrosis.
Fang Q; Wang J; Zhang Y; Wang L; Li W; Han J; Huang W; Liang G; Wang Y
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):252-262. PubMed ID: 28965884
[TBL] [Abstract][Full Text] [Related]
15. Alternative Mitophagy Protects the Heart Against Obesity-Associated Cardiomyopathy.
Tong M; Saito T; Zhai P; Oka SI; Mizushima W; Nakamura M; Ikeda S; Shirakabe A; Sadoshima J
Circ Res; 2021 Dec; 129(12):1105-1121. PubMed ID: 34724805
[TBL] [Abstract][Full Text] [Related]
16. Tabersonine alleviates obesity-induced cardiomyopathy by binding to Transforming growth factor activated kinase 1 (TAK1) and inhibiting TAK1-mediated inflammation.
Chen Y; Lin W; Chen P; Ye B; Luo W; Wang X; Huang W; Wu G; Liang G
Phytother Res; 2023 Mar; 37(3):860-871. PubMed ID: 36420902
[TBL] [Abstract][Full Text] [Related]
17. Endoplasmic reticulum stress-induced iRhom2 up-regulation promotes macrophage-regulated cardiac inflammation and lipid deposition in high fat diet (HFD)-challenged mice: Intervention of fisetin and metformin.
Ge CX; Xu MX; Qin YT; Gu TT; Lou DS; Li Q; Hu LF; Wang BC; Tan J
Free Radic Biol Med; 2019 Sep; 141():67-83. PubMed ID: 31153974
[TBL] [Abstract][Full Text] [Related]
18. Bicyclol Attenuates Obesity-Induced Cardiomyopathy via Inhibiting NF-κB and MAPK Signaling Pathways.
Chen Y; Lin W; Zhong L; Fang Z; Ye B; Wang Z; Chattipakorn N; Huang W; Liang G; Wu G
Cardiovasc Drugs Ther; 2023 Dec; 37(6):1131-1141. PubMed ID: 35750941
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptor 2 deficiency ameliorates obesity-induced cardiomyopathy via inhibiting NF-κB signaling pathway.
Qian C; Xu D; Wang J; Luo Y; Jin T; Huang L; Zhou Y; Cai Z; Jin B; Bao H; Wang Y
Int Immunopharmacol; 2024 Feb; 128():111551. PubMed ID: 38278067
[TBL] [Abstract][Full Text] [Related]
20. Importance of leptin signaling and signal transducer and activator of transcription-3 activation in mediating the cardiac hypertrophy associated with obesity.
Leifheit-Nestler M; Wagner NM; Gogiraju R; Didié M; Konstantinides S; Hasenfuss G; Schäfer K
J Transl Med; 2013 Jul; 11():170. PubMed ID: 23841921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
